25157358|t|Pinocembrin protects human brain microvascular endothelial cells against fibrillar amyloid-beta(1-40) injury by suppressing the MAPK/NF-kappaB inflammatory pathways.
25157358|a|Cerebrovascular accumulation of amyloid-beta (Abeta) peptides in Alzheimer's disease (AD) may contribute to disease progression through Abeta-induced microvascular endothelial pathogenesis. Pinocembrin has been shown to have therapeutic effects in AD models. These effects correlate with preservation of microvascular function, but the effect on endothelial cells under Abeta-damaged conditions is unclear. The present study focuses on the in vitro protective effect of pinocembrin on fibrillar Abeta(1-40) (fAbeta(1-40)) injured human brain microvascular endothelial cells (hBMECs) and explores potential mechanisms. The results demonstrate that fAbeta(1-40)-induced cytotoxicity in hBMECs can be rescued by pinocembrin treatment. Pinocembrin increases cell viability, reduces the release of LDH, and relieves nuclear condensation. The mechanisms of this reversal from Abeta may be associated with the inhibition of inflammatory response, involving inhibition of MAPK activation, downregulation of phosphor-IKK level, relief of IkappaBalpha degradation, blockage of NF-kappaB p65 nuclear translocation, and reduction of the release of proinflammatory cytokines. Pinocembrin does not show obvious effects on regulating the redox imbalance after exposure to fAbeta(1-40). Together, the suppression of MAPK and the NF-kappaB signaling pathways play a significant role in the anti-inflammation of pinocembrin in hBMECs subjected to fAbeta(1-40). This may serve as a therapeutic agent for BMEC protection in Alzheimer's-related deficits.
25157358	0	11	Pinocembrin	Chemical	MESH:C016063
25157358	21	26	human	Species	9606
25157358	83	95	amyloid-beta	Gene	351
25157358	133	142	NF-kappaB	Gene	4790
25157358	143	155	inflammatory	Disease	MESH:D007249
25157358	198	210	amyloid-beta	Gene	351
25157358	212	217	Abeta	Gene	351
25157358	231	250	Alzheimer's disease	Disease	MESH:D000544
25157358	252	254	AD	Disease	MESH:D000544
25157358	302	307	Abeta	Gene	351
25157358	356	367	Pinocembrin	Chemical	MESH:C016063
25157358	414	416	AD	Disease	MESH:D000544
25157358	536	541	Abeta	Gene	351
25157358	636	647	pinocembrin	Chemical	MESH:C016063
25157358	696	701	human	Species	9606
25157358	834	846	cytotoxicity	Disease	MESH:D064420
25157358	875	886	pinocembrin	Chemical	MESH:C016063
25157358	898	909	Pinocembrin	Chemical	MESH:C016063
25157358	1036	1041	Abeta	Gene	351
25157358	1083	1095	inflammatory	Disease	MESH:D007249
25157358	1195	1207	IkappaBalpha	Gene	4792
25157358	1233	1246	NF-kappaB p65	Gene	5970
25157358	1329	1340	Pinocembrin	Chemical	MESH:C016063
25157358	1479	1488	NF-kappaB	Gene	4790
25157358	1544	1556	inflammation	Disease	MESH:D007249
25157358	1560	1571	pinocembrin	Chemical	MESH:C016063
25157358	1595	1607	fAbeta(1-40)	Chemical	-
25157358	1670	1698	Alzheimer's-related deficits	Disease	MESH:D000544
25157358	Negative_Correlation	MESH:C016063	MESH:D007249
25157358	Association	MESH:D000544	351
25157358	Negative_Correlation	MESH:C016063	4792
25157358	Association	MESH:D007249	351
25157358	Negative_Correlation	MESH:C016063	351
25157358	Negative_Correlation	MESH:C016063	MESH:D064420
25157358	Association	MESH:D007249	4790
25157358	Association	351	4792
25157358	Negative_Correlation	MESH:C016063	4790
25157358	Negative_Correlation	MESH:C016063	5970
25157358	Negative_Correlation	MESH:C016063	MESH:D000544

